Immune checkpoint molecules, such as PD-1/PD-L1 and CTLA-4, are critical mediators of tumor immune escape, enabling tumor cells to evade immune surveillance by binding to receptors on T cells and suppressing their activity. This evidence concerns the gene CTLA4 and neoplasm.